Synthio Labs GTM brain

Synthio Labs sells conversational AI agents and copilots to life sciences commercial, medical and patient engagement teams.

category

Life sciences conversational AI

market profile

  • text: Pharma commercial organizations must engage HCPs and patients while maintaining clinical and regulatory controls.
  • text: The platform spans field enablement, HCP and patient conversations, and simulated market research, creating multiple potential entry points within a pharma account.
  • text: Veeva Ostro and Medisafe VIA address overlapping HCP or patient engagement workflows.

personas

  • title: VP Commercial Excellence or Field Operations
    pains:
    • Reps lose selling time to documentation and preparation.
    • Field teams need consistent, accessible information for HCP conversations.
  • title: Head of Medical Information or HCP Engagement
    pains:
    • Clinicians need timely, clinically accurate answers outside staffed hours.
    • Scientific communications must remain compliant at scale.
  • title: Patient Support Program Director
    pains:
    • Patients need support beyond a one-time transaction.
    • Growing volumes of conversations strain human support capacity.
  • title: Director of Marketing Insights
    pains:
    • Traditional qualitative research takes time and budgets.
    • Brand teams need actionable physician perspectives quickly.

icp

  • text: Large pharmaceutical manufacturers with field sales, medical affairs and multiple therapeutic brands are a strong enterprise fit.
  • text: Consumer healthcare brands with large patient support volumes are a secondary fit, as illustrated by Soteri Skin.
  • text: Teams running US HCP field engagement or oncology market research have use cases represented in published examples.

message pillars

  • text: Use voice AI to augment field teams and reduce administrative load.
  • text: Provide always-on answers to healthcare professionals.
  • text: Extend patient support through conversational agents.
  • text: Accelerate market research with simulated personas.

objections

  • objection: Can an AI answer clinical questions safely and compliantly?
    response: Review clinical validation, escalation rules and approved content controls in a limited pilot before expansion.
  • objection: Will field teams use another tool?
    response: Evaluate adoption and time saved in a representative field-team pilot, referencing the published Jarvis case.
  • objection: Are synthetic personas reliable enough for research?
    response: Compare outputs with conventional research on a defined question before using them for consequential decisions.

competitors

  • name: Veeva Ostro
    website: https://ostro.veeva.com/
    why: Conversational AI for compliant HCP and patient engagement.
  • name: Medisafe VIA
    website: https://www.medisafevia.com/
    why: Voice agents for pharma patient support and engagement.
  • name: ACTO LAICA
    website: https://acto.com/platform/laica/
    why: Voice and text knowledge assistance for life sciences field reps.

influencers

  • name: Supreet Deshpande
    url: https://www.linkedin.com/in/supreetdeshpande
    why: CEO who writes about AI adoption in pharma commercial and medical teams.

keywords

  • pharma HCP engagement AI
  • life sciences voice AI
  • pharma field sales copilot
  • patient support voice agent
  • AI pharma market research
  • medical information chatbot

voice

  • Clinically grounded
  • Ambitious and outcome oriented
  • Empathetic toward patients

signals

  • text: A pharma brand is launching or expanding an HCP engagement program and needs always-on medical information.
  • text: A field organization is investing in rep productivity or reducing documentation time.
  • text: A patient support program is struggling to handle growing inbound interactions.

pricing

model: unknown

motion

sales_led

channels

  • LinkedIn
  • founder thought leadership
  • customer case studies
  • YC launch

confidence

high

Founders

  • name: Supreet Deshpande
    title: Founder/CEO
    role: CEO
    bio: Building AI Agents for Life Sciences. Seasoned leader with over a decade at the intersection of AI/ML and life sciences, delivering AI solutions across the pharmaceutical value chain (Ex-McKinsey, Ex-ZS) Previously led "Gen AI for Life Sciences" initiatives at McKinsey; have worked with top 50 pharma companies and biotechs to implement AI applications. Worked across teams - from Clinical Development and Medical Affairs to Commercial.
  • name: Sahitya Sridhar
    title: Founder
    role: Founder
    bio: Building AI Agents for Life Sciences GTM at SynthioLabs. Previously built scalable AI systems for content personalisation and TTS at Audible. Led developer efficiency Gen AI initiatives for teams at Audible.
  • name: Rajashekar Vasantha
    title: Founder/CTO
    role: CTO
    bio: Building AI agents for Life Sciences @ SynthioLabs. Previously AI research at AWS and NYU CDS.

Back to YC companies